Member Info for chester18

Probably the most exciting thing about tonight is what kind of strike lengths / Au & Cu we see, plus what have we found in the growth drilling.

I'm not holding my breath waiting to see if we will have an upgrade to Indicated but it would be excellent if they did.

15 out of 15 outstanding drill core results will do just fine.

Chester.

hi TMT

My hope is that Havieron continues to expand in size and it becomes to expensive for Newcrest to buy it. I'm very comfortable as things are, watching this asset grow with each set of results. My hopes are that we do find another highly mineralised deposit at one of our licence's, if it were Scallywag that would be a fantastic result but any on the Juri JV is fine with me.

I've convinced myself that Wednesdays report will not include an increase in the Inferred or an upgrade to Indicated and I'll take it as a nice surprise if there is news on that front.

Chester.

The MRE currently at 4.2m ounces AU equivalent but from what I understand that is only approximately 15% of the whole mineralised body, which just keeps on growing with each quarterly report.

So if we reach 15m Ounces Inferred by the time the FS is being completed and gold does rise as some predict we could ask for $350/ounce in ground resource.
Also we may have only covered 60% or so of the resource and still be open especially at depth. Where do you draw the line at Havieron as it could ultimately be a 24m or 30m ounce asset.

Could Newcrest come up with $2b or $2.5b to buy just Havieron ?

Chester.

crumbs and Bermudashorts, thank you for pointing out that SCIB 1/ Keytruda is already advanced to the point of patient recruitment (trial site permitting) and that there are CRO's that do the heavy lifting in setting up clinical trials. Taking both of those away from my earlier post still leaves a considerable amount of daily work for our smallish team.

I can imagine that while we are debating the 'whys' and 'where for's' of the impending trial starts the Scancell employees are steadily and conscientiously beavering away to bring these trials into being.

The 'media flurry' of 6/ 8 weeks ago with the 'starting in weeks' emphasis has cause some impatience and continuous 7.00am weekday RNS checking, when CH has stated in a Proactive Investors interview that the Covidity Trial will start mid year (and I'm convinced he has said early H2).

I hold to my assumption that we need to hear something by Mid May (3 weeks) to ensure the trial does start at the promised time. We certainly do not want any back tracking or we risk the gates of 'Team Damp Hell', opening up....and we most certainly don't want that.

Chester.

There is one area where the relatively small size of Scancell can impede swift progress and that is Trial Documentation and Admin. Larger Pharma companies will teams or departments of 'trial set up' expertise.

We are currently aiming to launch three trials in the next 3 to 6 months and I would presume there are many critical hoops and hurdles to overcome.

IMHO I think the science could be virtually ready to go, maybe some tweaks to the new delivery platform but on the whole ready.

Putting together all the Trial Documentation, the Trial Design, the Trail Control Disciplines, setting up of the various Trial Centres and the Trial Staffing and Training, must be a work of art. We are doing this on three separate Trials.

I have mentioned this before, Cliff said that the Covidity Trial will start early part of H2 2021, to achieve that, all of the above mentioned preparatory work must be completed and trial approval paperwork submitted, I would suggest by Mid May, to gain approval in June and actual start July / August.

News 'should' land anytime from tomorrow morning up to 15th May ish.

Once Scancell starts this process the board will be flooded with a multitude of new voices, so let's enjoy as much amicable debate as possible before that influx begins.

Chester.

Hi Greb

We have endured the news barren first quarter that will happen until the drilling season gets underway.
I think the market / traders have had their fun and now its about regular news flow.

I hope Zoros doesn't mind but I've pinched a section of his / her post to highlight the potential news from the end of April through to the 'big one' at the end of July.

Ex Zoros post :
04/21. Rigs at Paterson Range East and Black Hills. (Tama, N5,A9).
29/04/21. NCM March quarterly results.
Q2/21. MRE(Indicated) for SE Crescent and Breccia.
12/05/21. Ernest Giles mining rights expire. (Applications in to renew mining rights (30/3/21))
06/21. NCM Interim report. (Northern crescent and breccias?).
06/21. GDXJ quarterly rebalance. .
22/07/21. NCM June quarterly results. ****

Plenty there to see the back of 30p

Chester.

The trades who have bought in these last two weeks will sell either before the close on Wednesday or by noon on Thursday. The SP may retrace a little but as has happened many times I'm expecting the re-energised positive sentiment to push the SP higher over the following weeks.

An important thing is, do we see an upgrade in the Inferred MRE or is it converted to Indicated in next weeks report ?

If there is no change in the 4.2m AU equivalent resource this time it means that July's Newcrest update could be a huge leap in Havierons confirmed value.

Chester.

Happy Birthday. C7....

I wish you all the good things in life, like

good health, a great run up of our beloved Scancell shares, great times with your friends and not getting banned off LSE.....

plus good luck tomorrow against Moyes's Men..

Chester.

We've seen an excellent rise due to just one Clinical Labs deal. Between now and the next FDA decision (approx August ish) we could see 5 to 10 more Labs deals. The size of those deals will depend whether its a Ph1, Ph2 or Ph3 Trial. A few Ph3's would do very nicely. I see £2.00 / share being 'past by' very easily on just two more signed contracts of a similar worth to the First.

Chester.

I'm not talking about the next 3 months, I'm talking long term to build up the company over 5 years. Lets have some faith in why we brought in Shaun Day and let's have some ambition over the long term.

I don't agree that Newcrest would want to buy GGP in total, yes they will probably like to own all of Havieron but it might just become to large for them to buy outright.

We won't know just how valuable our shares are for at least 18 months and even then we may have many other assets in play.

Vote 'for' on both resolutions on the basis of offering the best possible flexibility to our CEO as he develops his vision of Greatland Golds future.

Chester.

I've voted in favour of both resolutions because I believe Shaun Day needs to have that flexibility, if he perceives an opportunity where he needs to act quickly and quietly. We know that deals can be done on the basis of cash plus shares.

Greatland Gold has a perfectly sound BOD and I trust that SD has joined the company to increase and build us into an £8 to £10 billion MCap Co.

Why would we want to hamper the CEO in doing his job.

Chester.

Yep, thanks mitchoftheday

I also only put £1.50 which would be a tiny deal.......!!

Contact worth $1.2M or as you say £825k over 18 months. With the potential Cancer Trail market running at 2,000 + Trials I would expect many contracts coming in over the next two years. Even if we are very conservative and say 50 such contracts averaging £300k per annum that's £15M revenue. I would expect any 'Phase III' contracts to be much larger.

Chester.

Morning Krayl49

The 1st October was exactly 12 months into the future when I raised the Idea. At the time there was little or no news on the horizon and the board was pretty quiet. I thought it would be good to change our focus from the Covid Pandemic towards the potential rise of TRX once the world had a chance of being back to normal.

What ever 'normal' is going to be in the future.

TRX is going to be a fairly good Barometer of the vaccine roll out success in the US, UK and Europe, as Elective Surgery is allowed to expand TRX will have the opportunity to grow. The next 12 months will see the addition of another 10 Clean Rooms in San Antonio which will quadruple the current output.

Predictions on revenues have been muted at 60% / 70% growth per annum, now that is a rare opportunity to have.

Chester.

1st Posted on 31st March, todays first contract at £1.5 over 18 months fits perfectly with my assumption.

'Angle PLC Global launch of clinical services laboratories' ................

The potential revenues of the Clinical Services Labs of Angle PLC will be the size of a small AIM listed company on their own.

Past businesses have launched on far less potential. Angle can develop their Laboratory Services as a Division of the company generating yearly revenue completely separate from an approved Parsortix Division sales.

The current SP now has an underpinning business and is not held to ransom to a 'Binary Play' based on whether Parsortix is approved in August 2021 or sometime in 2022.

I fully expect approval by the FDA this year but my point is that the business now has two potential revenue laboratories which makes my investment so much more secure.

Just my opinion but based on the solidity of Angles announcement that the two Clinical Services Labs are now open for business and that contacts are ready to be signed up.

Chester.

I posted similar to this a month ago, but now feel it is much more relevant on the 15th April...

Patience is needed, the application to enter a Phase1 Trial for Covidity will be being put together right now.

My take on everything said by our CEO Cliff Holloway plus what was reported in the media blitz seven or eight weeks ago, suggests that the Covidity trial will start very early H2 so in mid July / August. The application for the trial will be completed and submitted sometime Late April / Early May, hopefully in the next two weeks would be nice.

Without any news from Covidity for at least a month it may well be that we hear details of one of the Cancer trials by RNS first.

Scancell are on the cusp of launching three trials and each one has to be carefully designed, the clinics need to be arranged and the oversight by Scancell staff be thoroughly prepared.

So patience is needed for at least another 2 to 4 weeks.
It will soon pass, so don't stress.

Chester.

HI LivenLearn

Thank you for joining in. I started the prediction idea on the 1st October last year on the basis of where TRX might be in 12 months time. Now its close to only 6 months to go. Time races on, lets hope that the combined vaccines do their job and allow the opening of more Elective Surgery .

I would be very happy for your 1.38p prediction to be the winner as it will mean that we have signed those new contracts and confirmed that sales are building rapidly.

Just to add that demand for TRX products were consistently high, right through a very tough 2020, so as soon as the re-fit and Ph1 expansion have increased output our turnover will rise and with a 60% profit margin it should reflect very rapidly in the SP.

Chester.

Traders T10 notes now expire on the 28th so the 10%ers should begin buying tomorrow or Friday. This is why we always see a rise towards the Newcrest Quarterly and then a dip more or less on the day / day after.

The April 28th will be the 15th out of 15 superb drill core reports, again some solid Infill and let's hope some dramatic step out drills.

Chester

Good Afternoon all TRX investors

I neglected to post this last week but it's here now.

So the SP had reached around .90p and then slid back to .59p which I missed out on because that was a low price for this share.
The current price is still very good value set against the potential growth now we have the Phase 1 upgrades more or less ready to go. On our 'Bit of Fun' prediction competition here are the current Runners and your Guesstimations as to where the SP will be at the Closing SP on Friday 1st October 2021 which is just over 6 months away.

Thank you to all of you that have pledged your * £25 or the *** £100 if we reach 2.5p per share and Sinden888 who has **** and has said if it reaches 2.5p he will donate a grand, which is magnificent. The person with the nearest guess can nominate a Charity of their choice for everyone to donate to.

JonnyRod. 0.20p
Nomlungu. 0.30p*
Sinden888. 0.57p ****
Jurado. 0.62p
CURRENT PRICE >>>>>>>>>>>0.65p >>>>
MRK2020. 0.70p*
TheOldBee. 0.79p*
ChrissyDude. 0.83p
Chester. 0.91p***
Stuofthetoon . 0.95p
GinandMilk. 0.97p
KJM100K. 1.01p***
Scoobyrex. 1.08p
DoneK. 1.1p
JoeSoap1. 1.19p*
Andysmi. 1.20p
LunchBoxBill. 1.21p*
theAccountant. 1.25p
Ohmni. 1.27p***
HBomb5. 1.28p*
Mark@1973. 1.30p
SC888. 1.31p
Messi10. 1.45p*
Owennoone. 1.48p *
theonlywayis.. 1.50p*
Danielu11 1.51p*
RN1MLT 1.56p ***
Shovel53. 1.57p
Smokey2. 1.68p ***
Jimjam. 1.70p***
Sandhopper 1.75p*
learn19 1.80p
Icecool. 1.99p*
Krayl49 2.00 ****
littlebricks 2.06p*
Specialonek 2.50p***
brittany 2.77p
ISATony 3.35p ***

I think its about time we heard something about the potential New Contracts as intimated by our new CEO.

Chester.

Tomorrow morning the count down clock enters the Red Zone as far news is concerned.

Chester.

Also a very interesting point to add to that, to advance the Coronavirus play all of Scancells BOD took a 30% pay cut on the announcement. When Redmile put in their first investment they knew that the pandemic meant that starting cancer trials was going to be very difficult and about the BODs commitment to Covidity.

If I were a Redmile executive I would now be squarely behind Scancell getting the Covid Vaccine , Immunobody , AvidiMab product into clinical trials ASAP.
Hopefully with the Cancer Platforms as a 'Brucey Bonus'....

Chester.